NEXTCURE, INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEXTCURE, INC stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $14.00K.
- NEXTCURE, INC stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $22.00K, a 340.00% increase year-over-year.
- NEXTCURE, INC stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $1.00K.
- NEXTCURE, INC stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $5.00K, a 16.67% decline year-over-year.
- NEXTCURE, INC stock issued during period, value, stock options exercised for fiscal 2023 was $5.00K, a 92.42% decline from fiscal 2022.
- NEXTCURE, INC stock issued during period, value, stock options exercised for fiscal 2022 was $66.00K, a 68.27% decline from fiscal 2021.
- NEXTCURE, INC stock issued during period, value, stock options exercised for fiscal 2021 was $208.00K, a 85.71% increase from fiscal 2020.
- NEXTCURE, INC stock issued during period, value, stock options exercised for fiscal 2020 was $112.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $14.00K S-4 · filed 2026-08-18 | |
| 2024-12-31 | $23.00K S-4 · filed 2026-08-18 | |
| 2024-06-30 | $22.00K 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $1.00K 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $5.00K 10-K · filed 2025-03-06 | |
| 2023-06-30 | $5.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $66.00K 10-K · filed 2024-03-21 | |
| 2022-06-30 | $6.00K 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $60.00K 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $208.00K 10-K · filed 2023-03-02 | |
| 2021-09-30 | $9.00K 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $13.00K 10-Q · filed 2022-11-03 | |
| 2021-03-31 | $63.00K 10-Q · filed 2022-11-03 | |
| 2020-12-31 | $112.00K 10-K · filed 2022-03-03 | |
| 2020-09-30 | $54.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $3.00K 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $37.00K 10-Q · filed 2021-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |